Cervical Cancer (Screening)

Coverage Approved for ThinPrep Pap Test

Published in Cancer Weekly, February 24th, 1997

Blue Cross Blue Shield of Massachusetts, Boston, announced that it has approved coverage for the ThinPrep Pap Test for cervical cancer screening from Cytyc Corporation.

The unanimous decision, based upon a technical review by the Medical Policy Group, concluded that the increased effectiveness of the ThinPrep Pap Test leads to improved cervical cancer detection for its members.

"Providing a more effective Pap test to our female members is a fundamental part of our continuing commitment to women's healthcare," said Anne L. Meneghetti, M.D., Blue Cross Blue Shield. "Following a careful comparison of ThinPrep to existing cervical cancer screening...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1997-02-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry